This editorial has been updated to remove an incorrect reference to a planned late April meeting of the Lancaster County ...

The Lancaster County Health Advisory Council will in the next 30 days compose a recommendation that the county undertake a ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Fitch revised Pittsburgh-based UPMC’s outlook to stable from negative and affirmed its “A” rating. The revision reflects UPMC’s material operating performance improvement in 2025, Fitch said in a ...

Is the White House putting a leash on Food and Drug Administration vaccine chief Vinay Prasad? Americans can hope so after the agency on Wednesday walked back Dr. Prasad’s startling summary refusal ...

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail—and about as elusive as a mythological vessel. But Stanford Medicine ...

The Food and Drug Administration reversed an earlier decision to not review Moderna's flu vaccine and will evaluate the company's modified application for a potential approval, Moderna said on Feb. 18 ...

On January 5th, the Department of Health and Human Services, under the direction of Robert F. Kennedy, Jr., removed several vaccines from the universally recommended schedule for children: hepatitis A ...

Add Yahoo as a preferred source to see more of our stories on Google. Sarah Silbiger/Getty Images Moderna announced the Food and Drug Administration (FDA) will review its new mRNA flu vaccine, ...

YORK, Pa. — Family members, hospital staff, and law enforcement gathered at UPMC Memorial on Saturday evening for a candlelight vigil marking one year since the shooting that killed Officer Andrew ...

Dr. Ralph Abraham, the agency’s principal deputy director, has called the Covid vaccines “dangerous.” Other skeptics have recently left federal health roles. By Apoorva Mandavilli Adding to a rapid ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.